Product

Group A and C Meningococcal Polysaccharide Conjugate Vaccine

Aliases

Group A and C Meningococcal Polysaccharide Conjugate Vaccine (producted by Olymvax), Group A and C Meningococcal Polysaccharide Conjugate Vaccine (producted by Walvax), Group A and C Meningococcal Polysaccharide Conjugate Vaccine (producted by Zhifei Lvzhu)

1 clinical trial

1 indication

Indication

Healthy Population

Clinical trial

A Single-center, Randomized, Blind, Positive Control Phase III Clinical Trial to Evaluate Immunogenicity and Safety of Group A and C Meningococcal Polysaccharide Conjugate Vaccine in Volunteers Aged 3-5 Months

Status: Active (not recruiting), Estimated PCD: 2024-12-30